Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#151 / 200 Total
NVAX - Novavax, Inc. - Stock Price Chart
TickerNVAX [NASD, RUT]
CompanyNovavax, Inc.
CountryUSA
IndustryBiotechnology
Market Cap2.08BEPS (ttm)-3.18
P/E-EPS this Y101.17%
Forward P/E-EPS next Y-968.43%
PEG-EPS past 5Y11.55%
P/S2.08EPS next 5Y37.90%
P/B-EPS Q/Q69.08%
Dividend-Sales Q/Q15.94%
Insider Own4.98%Inst Own56.59%
Insider Trans-0.67%Inst Trans3.20%
Short Float33.68%EarningsMay 10/b
Analyst Recom2.00Target Price18.00
Avg Volume12.96M52W Range3.53 - 15.00
Today 06:27AM The $10 Stock Jackpot: 3 Speculative Plays That Could Double Overnight (InvestorPlace)
May-20-24 03:29PM Moderna and Novavax Hope for Early Launch of This Years Covid-19 Shots (Barrons.com) +13.68%
02:31PM Moderna and Novavax Hope for Early Launch of This Years Covid-19 Shots, Despite FDA Delay (Barrons.com)
01:53PM Hedge Fund and Insider Trading News: Ray Dalio, Michael Burry, David Tepper, Elliott Management, Greenlight Capital, Ghisallo Capital Management, Millennium Management, Nextnav Inc (NN), Williams-Sonoma, Inc. (WSM), and More (Insider Monkey)
01:37PM Roaring Kitty's Rally Cry: 3 Meme Stocks to Pounce On Now (InvestorPlace)
07:40AM Novavax Stockholder Shah Capital Withdraws Campaign Against Reelection of Directors (MT Newswires)
07:39AM Shah Capital ends campaign against Novavax board after Sanofi deal (Reuters)
06:35AM Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax's 2024 Annual Meeting (GlobeNewswire)
May-19-24 08:49AM This Stock Just More Than Doubled in 1 Day: Is It a Buy? (Motley Fool)
May-18-24 07:35AM Is Novavax Stock a Buy? (Motley Fool)
TKNO - Alpha Teknova Inc - Stock Price Chart
TickerTKNO [NASD]
CompanyAlpha Teknova Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap73.07MEPS (ttm)-1.05
P/E-EPS this Y41.16%
Forward P/E-EPS next Y13.19%
PEG-EPS past 5Y-113.92%
P/S1.98EPS next 5Y-
P/B0.88EPS Q/Q36.59%
Dividend-Sales Q/Q1.85%
Insider Own74.24%Inst Own14.70%
Insider Trans0.04%Inst Trans-1.24%
Short Float0.49%EarningsMay 13/a
Analyst Recom1.80Target Price5.50
Avg Volume11.17K52W Range1.66 - 4.27
May-13-24 08:55PM TKNO Stock Earnings: Alpha Teknova Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:17PM Alpha Teknova: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM Teknova Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-07-24 10:00AM Teknova Launches Proprietary Build-Tek Solutions Custom Configurator and Latest AAV-Tek Product to Further Accelerate Novel Therapy Development (GlobeNewswire)
Apr-29-24 04:01PM Teknova to Report First Quarter 2024 Financial Results on May 13, 2024 (GlobeNewswire)
Apr-24-24 09:35AM Down -28.04% in 4 Weeks, Here's Why Alpha Teknova (TKNO) Looks Ripe for a Turnaround (Zacks)
Mar-13-24 08:12AM Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-11-24 05:35PM Alpha Teknova Inc (TKNO) Faces Revenue Decline Amid Market Challenges (GuruFocus.com) +5.96%
04:24PM Alpha Teknova: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM Teknova Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
BENF - Beneficient - Stock Price Chart
TickerBENF [NASD]
CompanyBeneficient
CountryUSA
IndustryAsset Management
Market Cap78.26MEPS (ttm)-279.47
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S132.64EPS next 5Y-
P/B-EPS Q/Q-363081.65%
Dividend-Sales Q/Q-
Insider Own95.26%Inst Own2.94%
Insider Trans1.91%Inst Trans132.58%
Short Float6.14%EarningsFeb 13/a
Analyst Recom-Target Price-
Avg Volume864.26K52W Range1.86 - 1320.00
May-06-24 07:28AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -12.02%
May-03-24 04:02PM Why Is Beneficient (BENF) Stock Up 390% Today? (InvestorPlace) +255.21%
08:00AM Beneficient Regains Compliance with NASDAQ Minimum Bid Price Rule (GlobeNewswire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE) -9.72%
Apr-22-24 07:00AM Beneficient Responds to Claims Made by GWG Litigation Trustee (GlobeNewswire) +22.45%
Apr-16-24 07:00AM Beneficient Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price (GlobeNewswire) -17.78%
Apr-15-24 04:15PM Beneficient to Participate in the Planet MicroCap Showcase on May 1-2, 2024 (GlobeNewswire) -7.60%
Mar-06-24 05:00PM Beneficient Enters into New Liquidity Transaction with ff Venture Capital (GlobeNewswire)
Feb-23-24 08:21AM Why Is Beneficient (BENF) Stock Up 25% Today? (InvestorPlace) -10.05%
Feb-14-24 08:21AM Beneficient (NASDAQ:BENF) Q3 2024 Earnings Call Transcript (Insider Monkey)
UK - Ucommune International Ltd - Stock Price Chart
TickerUK [NASD]
CompanyUcommune International Ltd
CountryChina
IndustryReal Estate Services
Market Cap1.58MEPS (ttm)-5.37
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-250.49%
P/S0.02EPS next 5Y-
P/B0.16EPS Q/Q-719.46%
Dividend-Sales Q/Q12.70%
Insider Own18.84%Inst Own0.02%
Insider Trans0.00%Inst Trans-0.46%
Short Float3.54%Earnings-
Analyst Recom-Target Price-
Avg Volume170.58K52W Range1.80 - 12.60
Dec-15-23 06:30AM Ucommune Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire) -5.14%
Dec-14-23 06:30AM Joining Hands Towards a Shared Future----Signing Ceremony of Strategic Cooperation Between Ucommune and New World Development (Wuhan) Limited & Forum on Optimizing Building Economy and Collaborating for Breakthrough Development Successfully Held (PR Newswire)
Nov-29-23 09:00AM Ucommune Announces Extraordinary General Meeting Results and Share Consolidation (PR Newswire) +45.63%
Oct-24-23 07:30AM Ucommune and Plateno Hotel: A Powerhouse Partnership Set to Transform the Hotel and Co-working Space (PR Newswire) +7.92%
Oct-13-23 05:00PM Ucommune Announces Extraordinary General Meeting (PR Newswire) +8.10%
Jul-24-23 04:00PM Ucommune Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (PR Newswire)
Jan-03-23 06:30AM Ucommune Launches "Up to U" Digital Apartment Management Platform (PR Newswire)
Oct-26-22 07:00AM Ucommune Delivers Customized Office Space with All-In-One Solution (PR Newswire) -13.96%
Oct-11-22 07:00AM Ucommune and Zhuhai Gree Real Estate Co., Ltd. Enter into an Agreement to Create a Benchmark Coworking Space in Greater Bay Area, China (PR Newswire) +5.95%
Oct-04-22 07:00AM Ucommune Completes Digital Operation Management Across All Its Managed Locations Using SaaS (PR Newswire)
IKT - Inhibikase Therapeutics Inc - Stock Price Chart
TickerIKT [NASD]
CompanyInhibikase Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap12.05MEPS (ttm)-3.37
P/E-EPS this Y43.42%
Forward P/E-EPS next Y28.71%
PEG-EPS past 5Y-23.31%
P/S60.26EPS next 5Y-
P/B1.78EPS Q/Q24.91%
Dividend-Sales Q/Q-100.00%
Insider Own13.85%Inst Own6.71%
Insider Trans0.00%Inst Trans-20.47%
Short Float2.42%EarningsMay 16/b
Analyst Recom1.00Target Price17.50
Avg Volume65.80K52W Range0.79 - 4.35
May-20-24 08:01AM Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $4.0 Million (GlobeNewswire) +7.51%
May-19-24 08:09AM Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-16-24 06:52AM IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q1 2024 (InvestorPlace) -11.56%
May-15-24 08:00PM Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity (GlobeNewswire) +29.22%
08:45AM Inhibikase Therapeutics Announces Request for Withdrawal of S-1 Registration Statement (GlobeNewswire)
May-09-24 08:00AM Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension (GlobeNewswire)
Apr-18-24 04:30PM Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs (GlobeNewswire)
Apr-03-24 08:05AM Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension (GlobeNewswire)
Apr-02-24 10:25AM Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-28-24 09:06PM Q4 2023 Inhibikase Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -6.09%
UONE - Urban One Inc - Stock Price Chart
TickerUONE [NASD, RUT]
CompanyUrban One Inc
CountryUSA
IndustryBroadcasting
Market Cap118.78MEPS (ttm)0.22
P/E10.91EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-20.48%
P/S0.24EPS next 5Y-
P/B0.43EPS Q/Q-1459.00%
Dividend-Sales Q/Q-2.95%
Insider Own82.08%Inst Own7.87%
Insider Trans-0.00%Inst Trans-
Short Float4.55%EarningsJan 11/b
Analyst Recom1.00Target Price6.00
Avg Volume71.54K52W Range1.89 - 7.69
Apr-22-24 09:16AM 15 Most Black States in the US (Insider Monkey) -14.41%
Apr-12-24 04:50PM Urban One, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) (PR Newswire) -8.26%
Mar-13-24 09:24AM Veritone, Inc. (NASDAQ:VERI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 05:17AM 15 African Countries With English As Official Language (Insider Monkey)
Jan-12-24 01:49AM Q3 2023 Urban One Inc Earnings Call (Thomson Reuters StreetEvents)
Jan-11-24 06:45AM URBAN ONE, INC. REPORTS THIRD QUARTER 2023 RESULTS (PR Newswire)
Jan-03-24 01:43PM Urban One, Inc. Third Quarter 2023 Results Conference Call (PR Newswire)
Dec-27-23 10:51PM UONE Stock Earnings: Urban One Reported Results for Q3 2023 (InvestorPlace)
Dec-12-23 07:29PM Urban One Inc (UONE) Reports Mixed Results for First and Second Quarters of 2023 (GuruFocus.com)
Dec-08-23 09:10AM Urban One, Inc. (NASDAQ:UONE) Q2 2023 Earnings Call Transcript (Insider Monkey)
BTTR - Better Choice Company Inc - Stock Price Chart
TickerBTTR [AMEX]
CompanyBetter Choice Company Inc
CountryUSA
IndustryPackaged Foods
Market Cap2.82MEPS (ttm)-30.33
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y49.20%
P/S0.08EPS next 5Y-
P/B2.32EPS Q/Q28.49%
Dividend-Sales Q/Q-14.44%
Insider Own46.18%Inst Own7.70%
Insider Trans5.12%Inst Trans-71.46%
Short Float8.98%EarningsMay 17/b
Analyst Recom1.00Target Price176.00
Avg Volume272.01K52W Range2.94 - 25.52
May-17-24 12:49PM Better Choice Company Announces First Quarter 2024 Results (GlobeNewswire) -24.79%
Apr-30-24 04:00PM Better Choice is Encouraged by the Potential DEA Reclassification of Marijuana (GlobeNewswire) -13.92%
Apr-29-24 04:15PM Better Choice Company Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards (GlobeNewswire)
Apr-16-24 09:15AM Better Choice Company Board of Directors Authorize Stock Repurchase Program (GlobeNewswire) +23.53%
Apr-12-24 04:39PM Better Choice Company, Inc. Announces Fourth Quarter and Full Year 2023 Results (GlobeNewswire) -9.06%
Mar-26-24 09:15AM Better Choice Company Initiates Legal Action Against Alphia, a Portfolio Company of Private Equity Firm PAI (GlobeNewswire) -19.10%
Mar-08-24 04:05PM Better Choice Company To Effectuate a Reverse Stock Split (GlobeNewswire)
Mar-04-24 02:00PM Better Choice to Explore Non-Equity Related Capital Solutions to Fund the R&D of its Domestic Animal Targeted GLP1 Supplement (GlobeNewswire)
Feb-09-24 09:45AM Better Choice Acquires Aimia Pet Healthco to Enter the GLP1 Pet Market (GlobeNewswire) +24.64%
Nov-16-23 02:30PM Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs Second R&D Partnership Agreement with KGK Science for Development of GLP1 Supplement for Pets (GlobeNewswire)
DYN - Dyne Therapeutics Inc - Stock Price Chart
TickerDYN [NASD, RUT]
CompanyDyne Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.87BEPS (ttm)-3.97
P/E-EPS this Y21.41%
Forward P/E-EPS next Y-5.74%
PEG-EPS past 5Y-106.26%
P/S-EPS next 5Y-
P/B6.45EPS Q/Q-3.25%
Dividend-Sales Q/Q-
Insider Own34.17%Inst Own82.59%
Insider Trans-10.71%Inst Trans-3.15%
Short Float18.04%EarningsMay 02/a
Analyst Recom1.00Target Price45.67
Avg Volume1.29M52W Range6.40 - 30.27
TodayReiterated Chardan Capital Markets Buy $31 → $42
Today 07:17AM Chardan Raises Price Target on Dyne Therapeutics to $42 From $31, Cites Additional Positive Data on DYNE-101, DYNE-251; Buy Rating Kept (MT Newswires)
May-20-24 05:53PM Why Is Dyne Therapeutics Stock Soaring On Monday? (Benzinga) +27.82%
04:27PM Dyne Therapeutics Launches $300 Million Share Offering (MT Newswires)
04:07PM Why Dyne Therapeutics, With A 166% Run This Year, Just Catapulted Again (Investor's Business Daily)
04:01PM Dyne Therapeutics Announces Proposed Public Offering of Common Stock (GlobeNewswire)
11:22AM Update: Dyne Shares Rise After Trial Data of DYNE-101, DYNE-251 Showed Improvements in Functional Endpoints, Favorable Safety Profiles (MT Newswires)
09:40AM HC Wainwright Adjusts Price Target on Dyne Therapeutics to $48 From $46, Maintains Buy Rating (MT Newswires)
09:12AM Sector Update: Health Care Stocks Mixed Pre-Bell Monday (MT Newswires)
08:02AM Dyne shares jump on trial data for muscle disease drugs (BioPharma Dive)
07:47AM Dyne Says Trial Data of DYNE-101, DYNE-251 Showed Improvements in Functional Endpoints, Favorable Safety Profiles (MT Newswires)
BTCM - BIT Mining Ltd ADR - Stock Price Chart
TickerBTCM [NYSE]
CompanyBIT Mining Ltd ADR
CountryUSA
IndustryInformation Technology Services
Market Cap31.66MEPS (ttm)-1.31
P/E-EPS this Y200.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y31.01%
P/S0.14EPS next 5Y15.75%
P/B0.80EPS Q/Q96.72%
Dividend-Sales Q/Q-82.95%
Insider Own3.15%Inst Own0.51%
Insider Trans0.00%Inst Trans-82.46%
Short Float3.61%EarningsFeb 23/a
Analyst Recom5.00Target Price13.80
Avg Volume140.91K52W Range1.79 - 6.95
May-03-24 04:56PM Bitcoins Wild Price Swings Point to the Rising Influence of ETF Buyers (Bloomberg)
Mar-04-24 07:10AM BIT Mining Limited Completes Sale of its Mining Pool Business (PR Newswire)
Feb-23-24 04:35PM BIT Mining Limited Announces Unaudited Financial Results for the Fourth Quarter and Full Year ended December 31, 2023 (PR Newswire)
Feb-08-24 06:00AM BIT Mining Limited to Report Fourth Quarter and Full Year 2023 Financial Results on February 23, 2024 (PR Newswire) +14.41%
Dec-29-23 08:42AM BIT Mining Limited Agrees to Sell its Mining Pool Business (PR Newswire) -14.72%
Nov-17-23 04:35PM BIT Mining Limited Announces Unaudited Financial Results for the Third Quarter ended September 30, 2023 (PR Newswire)
Nov-10-23 06:00AM BIT Mining Limited to Report Third Quarter 2023 Financial Results on November 17, 2023 (PR Newswire)
Aug-18-23 04:05PM BIT Mining Limited Announces Unaudited Financial Results for the Second Quarter ended June 30, 2023 (PR Newswire)
Aug-11-23 06:00AM BIT Mining Limited to Report Second Quarter 2023 Financial Results on August 18, 2023 (PR Newswire)
Jul-07-23 04:10PM BIT Mining Limited Receives Notice Regarding NYSE Continued Listing Standards (PR Newswire) +5.08%
STRO - Sutro Biopharma Inc - Stock Price Chart
TickerSTRO [NASD, RUT]
CompanySutro Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap382.78MEPS (ttm)-1.89
P/E-EPS this Y-94.61%
Forward P/E-EPS next Y4.36%
PEG-EPS past 5Y21.96%
P/S2.48EPS next 5Y-12.88%
P/B2.98EPS Q/Q-11.13%
Dividend-Sales Q/Q2.64%
Insider Own3.32%Inst Own65.15%
Insider Trans-0.45%Inst Trans8.91%
Short Float2.60%EarningsMay 13/a
Analyst Recom1.18Target Price12.30
Avg Volume1.02M52W Range2.01 - 6.13
May-19-24 09:03AM Bank of America Predicts up to ~200% Surge for These 2 Strong Buy Stocks (TipRanks)
May-13-24 09:54PM STRO Stock Earnings: Sutro Biopharma Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:38PM Sutro Biopharma Q1 Loss Widens, Revenue Rises (MT Newswires)
04:30PM Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones (GlobeNewswire)
10:00AM Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for (Zacks)
May-08-24 07:17AM BofA Securities Starts Sutro Biopharma With Buy Rating (MT Newswires)
Apr-30-24 08:00AM Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFR ME-O1 Trial (GlobeNewswire)
Apr-02-24 06:18AM Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering (GlobeNewswire)
01:00AM Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors (GlobeNewswire)
Mar-26-24 09:02PM Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances (GuruFocus.com) +27.83%
1⋯1011121314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.